Parenteral Drugs (India) Ltd
PDPL
Price Chart
Scorecard
Performance
LowHasn't faired well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -0.15 | -0.02 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 32.79 | 3.97 | 0.98% |
Forecast & RatingsDetailed Forecast
Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Parenteral Drugs (India) Limited is a healthcare company. The Company is engaged in the manufacturing of allopathic pharmaceutical preparations.
PeersCompare with peers
Sun Pharmaceutical Industries Ltd
Dr Reddy's Laboratories Ltd
Cipla Ltd
Torrent Pharmaceuticals Ltd
Zydus Lifesciences Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Holdings TrendDetailed holdings
High Pledged Promoter HoldingLower pledged promoter holdings is considered better
A significant proportion of promoter holdings is pledged
Mutual Fund HoldingIncreasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock
In last 3 months, mutual fund holding of the company has almost stayed constant
Recent NewsAll news
Hmm, looks like data is unavailable here. Please come back after some timeRecent EventsAll events
Corporate Insolvency Resolution Process
Parenteral Drugs (India) Limited has informed the Exchange about Corporate Insolvency Resolution ProcessSubject: 1st COC meetingThis is to inform you that the 1st Meeting of Committee of Creditors of Parenteral Drugs (India) Limited Under CIRP will be held on 13/03/2023 at 4:30 PM through video conference / other audio-visual method. | Download
Parenteral Drugs (India) Limited has informed the Exchange about Corporate Insolvency Resolution ProcessSubject: 1st COC meetingThis is to inform you that the 1st Meeting of Committee of Creditors of Parenteral Drugs (India) Limited Under CIRP will be held on 13/03/2023 at 4:30 PM through video conference / other audio-visual method. | Download
Corporate Insolvency Resolution Process
Parenteral Drugs (India) Limited has informed the Exchange about Corporate Insolvency Resolution ProcessSubject: Formation of COCThis is to inform you that, the Committee of Creditors of Parenteral Drugs (India) Limitedunder CIRP has been formed as on 03/03/2023, and same has been informed to Hon ble NCLT. | Download
Parenteral Drugs (India) Limited has informed the Exchange about Corporate Insolvency Resolution ProcessSubject: Formation of COCThis is to inform you that, the Committee of Creditors of Parenteral Drugs (India) Limitedunder CIRP has been formed as on 03/03/2023, and same has been informed to Hon ble NCLT. | Download
Corporate Insolvency Resolution Process
Parenteral Drugs (India) Limited has informed the Exchange about Corporate Insolvency Resolution ProcessSubject: List of CreditorsThis is to inform you that, the list of Creditors of Parenteral Drugs (India) Limited Under CIRP has been prepared on 03/03/2023 and uploaded in IBBI Website on 04/03/2023 and the same has been informed to Hon ble NCLT. | Download
Parenteral Drugs (India) Limited has informed the Exchange about Corporate Insolvency Resolution ProcessSubject: List of CreditorsThis is to inform you that, the list of Creditors of Parenteral Drugs (India) Limited Under CIRP has been prepared on 03/03/2023 and uploaded in IBBI Website on 04/03/2023 and the same has been informed to Hon ble NCLT. | Download
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant